Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.
3.

Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1.

McCarthy SA, Chen D, Yang BS, Garcia Ramirez JJ, Cherwinski H, Chen XR, Klagsbrun M, Hauser CA, Ostrowski MC, McMahon M.

Mol Cell Biol. 1997 May;17(5):2401-12.

4.
5.

junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.

Coffer P, de Jonge M, Mettouchi A, Binetruy B, Ghysdael J, Kruijer W.

Oncogene. 1994 Mar;9(3):911-21.

PMID:
8108135
6.

Myc antagonizes Ras-mediated growth arrest in leukemia cells through the inhibition of the Ras-ERK-p21Cip1 pathway.

Vaqué JP, Navascues J, Shiio Y, Laiho M, Ajenjo N, Mauleon I, Matallanas D, Crespo P, León J.

J Biol Chem. 2005 Jan 14;280(2):1112-22. Epub 2004 Nov 4.

7.

Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding.

Kolch W, Philipp A, Mischak H, Dutil EM, Mullen TM, Feramisco JR, Meinkoth JL, Rose DW.

Oncogene. 1996 Sep 19;13(6):1305-14.

PMID:
8808705
8.

GHF-1/Pit-1 functions as a cell-specific integrator of Ras signaling by targeting the Ras pathway to a composite Ets-1/GHF-1 response element.

Bradford AP, Conrad KE, Tran PH, Ostrowski MC, Gutierrez-Hartmann A.

J Biol Chem. 1996 Oct 4;271(40):24639-48.

9.
10.
12.

Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.

Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V.

Oncogene. 2002 Apr 4;21(15):2309-19. Erratum in: Oncogene 2002 Jul 18;21(31):4872. Tulashe, David [corrected to Tulasne, David]; Reveneau, Syline [corrected to Reveneau, Sylvie].

13.

Phosphorylation-independent stimulation of DNA topoisomerase II alpha activity.

Kimura K, Saijo M, Tanaka M, Enomoto T.

J Biol Chem. 1996 May 3;271(18):10990-5.

14.

Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.

Takano H, Ise T, Nomoto M, Kato K, Murakami T, Ohmori H, Imamura T, Nagatani G, Okamoto T, Ohta R, Furukawa M, Shibao K, Izumi H, Kuwano M, Kohno K.

Anticancer Drug Des. 1999 Apr;14(2):87-92.

PMID:
10405635
15.

The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.

O'Hagan RC, Tozer RG, Symons M, McCormick F, Hassell JA.

Oncogene. 1996 Sep 19;13(6):1323-33.

PMID:
8808707
16.
17.
19.
20.

A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.

Ehrhardt GR, Korherr C, Wieler JS, Knaus M, Schrader JW.

Oncogene. 2001 Jan 11;20(2):188-97.

Supplemental Content

Support Center